Webinar: Regulatory updates & industry perspectives on NAMs for Medical Device Safety
Join us for an insightful webinar on the evolving role of New Approach Methodologies (NAMs) in regulatory biological safety assessments and how they can be used to help develop safe materials in the pre-regulatory space. With shifting standards and increasing adoption of NAMs, understanding their impact is more critical than ever.
In this webinar, Dr Andy Forreryd, our expert in in vitro skin sensitization and active member of ISO/TC 194/WG 8, will break down the latest regulatory updates on ISO 10993-10 and present new data from the GARD®skin Medical Device pre-validation study—a key milestone toward regulatory acceptance.
You will also hear from Dr Karla Lienau, Biological Safety Specialist and Research Engineer at Sonova, a global leader in Medical Devices, on how NAMs are shaping product development, ensuring compliance, and accelerating innovation.
Key takeaways
- Regulatory insights: Understand the latest developments in ISO 10993-10 and the role of in vitro methods.
- GARD® advancements: Learn how this technology supports skin sensitization testing for Medical Devices, solid materials and extracts in both polar and non-polar vehicles.
- Industry application: Discover how Sonova integrates NAMs into product development for novel materials.